Introduction And Epidemiology

• Chronic, inflammatory autoimmune disease.
• Characterized by progressive lymphocytic and plasma cell infiltration of exocrine glands.
• Affects primarily salivary and lacrimal glands.
• Rare in children.
• Mean age at diagnosis spans 9 to 10 years.
• Demonstrates strong female predominance approaching 75%.
• Classified as primary (isolated sicca complex) or secondary.
• Secondary disease occurs in association with systemic lupus erythematosus, scleroderma, or mixed connective tissue disease.

Etiology And Pathogenesis

• Results from complex interaction of genetic predisposition and potential infectious triggers.
• Autoantibodies (Anti-Ro/SSA, Anti-La/SSB) produced via B-cell activation.
• Features marked overproduction of interferons.
• Lymphocytes and plasma cells infiltrate salivary glands.
• Infiltration forms distinct periductal and periacinar foci.
• Foci become confluent, eventually replacing normal epithelial glandular structure.
• Regulated by apoptosis genes influencing chronicity of lymphocytic infiltration.

Clinical Manifestations

Glandular Features

• Recurrent parotid gland enlargement or parotitis represents the most common presentation in children (>70%).
• Painful or painless parotid swelling observed.
• Classic sicca symptoms include dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia).
• Sicca symptoms often less prominent or underreported in pediatric populations compared to adults.
• Widespread dental caries common secondary to xerostomia.
• Other exocrine features include decreased sense of smell and hoarseness.

Extraglandular And Systemic Features

• Systemic symptoms more prevalent in children than adults.
• Fever and lymphadenopathy occur in approximately 8% of cases.
• Polyarthritis or arthralgia noted in 18% of pediatric patients.
• Renal disease typically manifests as distal renal tubular acidosis or tubulointerstitial nephritis.
• Renal tubular acidosis presents clinically with polyuria, polydipsia, and hypokalemic paralysis.
• Medullary nephrocalcinosis visible on renal ultrasound.
• Pulmonary involvement includes diffuse interstitial lymphocytosis or interstitial lung disease.
• Neurological features encompass sensory/autonomic neuropathy and central nervous system involvement.
• Hematologic features include autoimmune hemolytic anemia and leukopenia.

Diagnostic Evaluation

Proposed Pediatric Classification Criteria

• Diagnosis requires minimum 4 of 12 proposed items.

Laboratory And Immunological Profile

• Markedly raised polyclonal hypergammaglobulinemia constitutes an important diagnostic marker.
• Complete blood count reveals leukopenia or anemia.
• Antinuclear antibody (ANA) positive in 40-70% of cases, typically exhibiting speckled pattern.
• Rheumatoid factor positive in up to 67% of cases.
• Specific autoantibodies include Anti-SSA (Ro) and Anti-SSB (La).

Specific Diagnostic Tests

• Schirmer test quantifies tear production. Utilizes Whatman filter paper No. 41 (5 mm x 35 mm). Wetting ≤5 mm in 5 minutes indicates positive result.
• Ocular surface damage detected via special dyes (fluorescein, Lissamine green).
• Salivary gland scintigraphy demonstrates reduced or delayed uptake.
• Salivary gland ultrasonography reveals characteristic cystic lesions.

Histopathology

• Minor salivary gland (labial) biopsy serves as gold standard.
• Pathological hallmark requires demonstration of focal lymphocytic sialadenitis.
• Focus score >1 per 4 mm² area (defined as cluster of >50 lymphocytes) confirms diagnosis.
• Children typically exhibit normal minor salivary gland biopsies but abnormal parotid biopsies.

Differential Diagnosis

• Juvenile recurrent parotitis: Features intermittent unilateral swelling, younger age onset (3-6 years), male predominance, and lacks focal lymphocytic infiltrates on biopsy.
• Infectious parotitis: Includes mumps, Epstein-Barr virus, cytomegalovirus, and HIV.
• Structural/Traumatic: Polycystic parotid disease, salivary duct calculi, local trauma.
• Other etiologies: Sarcoidosis, eating disorders, tumors.
• Sicca symptoms, specific autoantibodies, and rash remain absent in these differential conditions.

Management Strategies

• Requires tailored multidisciplinary intervention.
• Symptomatic Relief: Artificial tears, parotid massage, oral lozenges, and adequate hydration.
• Dental Care: Regular dental hygiene checks mandatory to prevent caries.
• Secretagogues: Pilocarpine hydrochloride utilized to increase salivary flow.
• Renal Management: Urinary alkalinizing agents indicated for renal tubular acidosis.
• Pharmacotherapy: Nonsteroidal anti-inflammatory drugs and hydroxychloroquine utilized for mild systemic symptoms.
• Corticosteroids: Administered for moderate systemic involvement.
• Immunosuppressants: Methotrexate or etanercept indicated for arthritis. Azathioprine utilized for progressive disease.
• Severe Disease: Cyclophosphamide, cyclosporine, or Rituximab reserved for life-threatening complications or severe visceral involvement, such as interstitial lung disease.

Complications And Prognosis

• Disease typically follows indolent, slowly progressive course.
• Overall 10-year survival rate exceeds 90% in pediatric patients.
• Diminished salivary flow persists indefinitely.
• Corneal damage represents significant morbidity if keratoconjunctivitis sicca remains untreated.
• Carries increased risk for mucosa-associated lymphoid tissue lymphoma, although incidence is significantly lower in children compared to adults.
• Maternal Sjögren syndrome strongly associated with risk of neonatal lupus and congenital heart block in offspring due to transplacental transfer of Anti-Ro/La antibodies.